BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cirrincione LR, Winston McPherson G, Rongitsch J, Sadilkova K, Drees JC, Krasowski MD, Dickerson JA, Greene DN. Sublingual Estradiol Is Associated with Higher Estrone Concentrations than Transdermal or Injectable Preparations in Transgender Women and Gender Nonbinary Adults. LGBT Health 2021;8:125-32. [PMID: 33439749 DOI: 10.1089/lgbt.2020.0249] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu J, Wang S, Li S, Liu X. To study the current status of uterine adhesions after fetal residue and the preventive effect of using estrogen and progesterone sequential therapy combined with Foley balloon. Medicine (Baltimore) 2022;101:e30418. [PMID: 36086686 DOI: 10.1097/MD.0000000000030418] [Reference Citation Analysis]
2 Doll E, Gunsolus I, Thorgerson A, Tangpricha V, Lamberton N, Sarvaideo JL. Pharmacokinetics of Sublingual vs. Oral Estradiol in Transgender Women. Endocr Pract 2021:S1530-891X(21)01374-4. [PMID: 34781041 DOI: 10.1016/j.eprac.2021.11.081] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Tebbens M, Heijboer AC, T'Sjoen G, Bisschop PH, den Heijer M. The role of estrone in feminizing hormone treatment. J Clin Endocrinol Metab 2021:dgab741. [PMID: 34632510 DOI: 10.1210/clinem/dgab741] [Reference Citation Analysis]
4 Balcerek MI, Nolan BJ, Brownhill A, Wong P, Locke P, Zajac JD, Cheung AS. Feminizing Hormone Therapy Prescription Patterns and Cardiovascular Risk Factors in Aging Transgender Individuals in Australia. Front Endocrinol (Lausanne) 2021;12:667403. [PMID: 34326812 DOI: 10.3389/fendo.2021.667403] [Cited by in F6Publishing: 1] [Reference Citation Analysis]